Experts debate over fibromyalgia, treatments

01/13/2008 | NYTimes.com

Patient advocates and some providers say the Pfizer drug Lyrica could help promote acceptance of fibromyalgia, a condition characterized by constant, widespread pain of unexplained origin. However, some health professionals don't consider the condition a medically recognizable illness and say that diagnosis could worsen the symptoms and that the drug could cause harmful side effects.

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID